Nu-Med Plus (NUMD) Operating Leases (2019 - 2022)

Nu-Med Plus has disclosed Operating Leases across 4 years of filings, most recently posting $2056.0 for Q2 2022.

• Operating Leases for Q2 2022 came in at $2056.0, up 3.06% year-over-year; the trailing twelve-month figure through Jun 2022 was $2056.0 (up 3.06% YoY), and the FY2021 annual result was $8222.0, up 3.02% from the prior year.
• Operating Leases came in at $2056.0 for Q2 2022 at Nu-Med Plus, down from $5138.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $11647.0 in Q3 2021 to a low of $1995.0 in Q2 2021.
• The 4-year median for Operating Leases is $5255.0 (2020), against an average of $6242.2.
• Across the five-year window, Operating Leases climbed 6.61% in 2020 and fell 7.15% in 2021, its largest moves.
• Nu-Med Plus' Operating Leases stood at $8396.0 in 2019, then retreated by 4.94% to $7981.0 in 2020, then rose by 3.02% to $8222.0 in 2021, then slumped by 74.99% to $2056.0 in 2022.
• The last three Operating Leases figures came in at $2056.0 (Q2 2022), $5138.0 (Q1 2022), and $8222.0 (Q4 2021), per Business Quant data.